Clinical Application of Molecular Biology: A Study of Allograft Rejection With Polymerase Chain Reaction

Xu-P, 1995, Intragraft expression of IL-10 messenger RNA: A novel correlate of renal allograft rejection, Kidney Int., 48, 1504, 10.1038/ki.1995.440 Sharma, 1996, Intragraft TGF-/51 mRNA: A correlate of in-terstitial fibrosis and chronic allograft nephropathy, Kidney Int., 49, 1297, 10.1038/ki.1996.185 Strom, 1975, Identity and cytotoxic capacity of cells infiltrating renal allografts, N Engl J Med., 292, 1257, 10.1056/NEJM197506122922402 Masson, 1987, A family of serine esterases in lytic granules of cytolytic T lymphocytes, Cell., 49, 679, 10.1016/0092-8674(87)90544-7 Lipman, 1992, The strong correlation of cytotoxic T lymphocyte specific serine protease gene transcripts with renal allograft rejection, Transplantation., 53, 73, 10.1097/00007890-199201000-00014 Heusel, 1994, Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells, Cell., 76, 977, 10.1016/0092-8674(94)90376-X Lichtenheld, 1988, Structure and function of human perforin, Nature., 335, 448, 10.1038/335448a0 Kagi, 1994, Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice, Nature., 369, 31, 10.1038/369031a0 Henkart, 1994, Lymphocyte-mediated cytotoxicity; two pathways and multiple effector molecules, Immunity., 1, 343, 10.1016/1074-7613(94)90063-9 Burke, 1995, Unlocking the secrets of CTL and NK cells, Immunology., 16, 343 Almond, 1993, Risk factors for chronic rejection in renal allograft recipients, Transplantation., 55, 752, 10.1097/00007890-199304000-00013 Mosmann, 1989, TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties, Annu Rev Immunol., 7, 145, 10.1146/annurev.iy.07.040189.001045 Nickerson, 1994, Cytokines and the Thl/Th2 paradigm in trans-plantation, Curr Opin Immunol., 6, 757, 10.1016/0952-7915(94)90081-7 Roberts, 1988, Transforming growth factor β, Adv Cancer Res., 51, 107, 10.1016/S0065-230X(08)60221-3 Massague, 1990, The transforming growth factor-β family, Annu Rev Cell Biol., 6, 597, 10.1146/annurev.cb.06.110190.003121 Carel, 1990, Transforming growth factor β decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon γ, Proc Natl Acad Sci USA., 87, 1591, 10.1073/pnas.87.4.1591 Wallick, 1990, Immunoregulatory role of transforming growth factor β (TGF-β) in development of killer cells: Comparison of active and latent TGF-β1, J Exp Med., 172, 1777, 10.1084/jem.172.6.1777 Li, 1991, Differential regulation of transforming growth factor β and interleukin-2 genes in human T cells: Demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction, J Exp Med., 174, 1259, 10.1084/jem.174.5.1259 Ayandar-Batuman, 1991, Regulation of transforming growth factor-β1 gene expression by glucocorticoids in normal human T lymphocytes, J Clin Invest., 88, 1574, 10.1172/JCI115469 van Obberghen-Schilling, 1985, Transforming growth factor-β1 positively regulates its own expression in normal and transformed cells, J Biol Chem., 262, 7741 Kurihara, 1989, Transforming growth factor β stimulates the expression of endothelin mRNA by vascular endothelial cells, Biochem Biophys Res Commun., 159, 1435, 10.1016/0006-291X(89)92270-5 Solez, 1993, International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology, Kidney Int., 44, 411, 10.1038/ki.1993.259